Overcoming the COVID-19 pandemic, we host a stage for sharing medical care

On the 29th, medical staff and scholars from 30 countries discussed treatment of tested positive patients and prevention of conversion to severe disease at both online and offline

[Medical newspaper/daily newspaper = Reporter Oh In-gyu] The 'International Conference on Sharing Hope Medical Care to Overcome the COVID-19 Pandemic' of the International Virus Research Alliance (IVRA), which is increasing its global reputation as a collaborative body for the treatment of COVID-19, will be held on the 29th at COEX and other venues. It is being held at both online and offline.

IVRA is growing into a reliable and successful gathering of global medical staff and scholars who have experienced the limitations of vaccines to end COVID-19. Through IVRA, scholars will actively respond to the future era of With Corona.

At this conference, ambassadors and commercial attachés from over 30 countries around the world participated to discover treatments by applying the principle that ‘hyperthermia treatment is effective for viral infections’ and to discuss various methods and the latest technology to treat positive COVID-19 patients and prevent them from becoming seriously ill. An opportunity to share knowledge is provided.

Dr. Yoo Seung-mo (Chairman of the Health and Healthcare Subcommittee of the Chungnam External Cooperation Strategy Committee) and Professor Kang-hyun Lee of Yonsei Severance (former Dean of Yonsei Severance Wonju University) were appointed as the first IVRA organizing committee chairs. On this day, South Chungcheong Province Governor Yang Seung-jo and Chairman Jinna of the UNWHD are expected to delivere congratulatory remarks.

Advisory members include former Dankook University Medical Center Director Park Woo-sung (Cancer Center Promotion Committee Chair), Catholic University School of Medicine Professor Jang Hong-seok, Yonsei University and Wonju University Professor Hwang Seong-oh, Catholic University School of Medicine Professor Kang Young-nam, Chung-Ang University College Professor Jeong Yun-jae, Soonchunhyang University School of Medicine Professor Kim Ho-jung, Kyung Hee University School of Medicine Professor Lee Hyeong-min, and Bundang Regenerative Hospital. A total of 50 people were appointed, including Center Director Kim Young-sik, Internal Medicine Director Jeong Young-ho, Yonsei Line Clinic Director Ahn Seong-hwan, Pangyo Yonsei Clinic Shin Hyeong-jin, Korean Balance Medical Association President Kim Gyeong-jin, and former Integrated Cancer Society President Choi Nak-won.

In addition, the Ambassador of Honduras to Korea and Sri Lanka participated in the event, as well as Commercial Attaché Claudia of Romania, Commercial Attaché Philip Winkler of Austria, Commercial Attaché Daniela Petrova of Bulgaria, Bwanga Kapumpa of Zambia, and Jose MA of the Philippines. Commercial Director Jojie, Cambodian Commercial Director Khath Chen, etc. will be present to raise the status of the conference.

This conference introduces the research results of Seosan Medical Center in South Chungcheong Province and related medical staff, adding value by applying the basic principle that the disease can be conquered through hyperthermia immunotherapy for viral infections. Expectations are high that remarkable treatment cases will emerge from the 20 or so COVID-positive patients who agreed to hyperthermia immunotherapy.

In particular, Seosan Medical Center, in cooperation with Seoul St. Mary's Hospital, will share and analyze the results of treating patients starting May 13th and present the information at the world's first IVRA conference to end the coronavirus.

The key is to discover a treatment for COVID-19 by applying the principle that hyperthermia treatment is effective in viral infection, and as predicted, it is helpful in treating asymptomatic or mild patients who are positive for COVID-19 and preventing the transition to severe disease.

Kim Seon-man, vice-chairman of IVRA, said, “It is the second year of the COVID-19 pandemic, and the world is making efforts to end the virus, but quarantine and preventive vaccines are not enough and there is no end in sight due to the increase in mutant viruses. IVRA is a leader in COVID-19 treatment.” “We place value on securing basic data for systematic clinical trials.”

 http://www.bosa.co.kr/news/articleView.html?idxno=2159019